STERIS plc — Director's Dealing 2020

Aug 3, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2020-07-28

Reporting Person: Madsen Julia (Senior VP, Life Sciences)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	3245	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$45.34	2023-05-31	Ordinary Shares (1100)		Direct
Employee Stock Option (right to buy)	$53.52	2024-05-30	Ordinary Shares (800)		Direct
Employee Stock Option (right to buy)	$66.15	2025-05-28	Ordinary Shares (700)		Direct
Employee Stock Option (right to buy)	$69.72	2026-06-01	Ordinary Shares (2700)		Direct
Employee Stock Option (right to buy)	$77.07	2027-05-30	Ordinary Shares (3252)		Direct
Employee Stock Option (right to buy)	$114.22	2028-05-31	Ordinary Shares (2872)		Direct
Employee Stock Option (right to buy)	$147.05	2029-05-31	Ordinary Shares (2136)		Direct
Employee Stock Option (right to buy)	$182.22	2030-06-01	Ordinary Shares (2984)		Direct

Footnotes

F1: 1,318 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 123 on June 3, 2024.

F2: This option is fully vested.

F3: This option becomes exercisable as follows: 813 May 30, 2018; 813 on May 30, 2019; 813 on May 30, 2020; and 813 on June 1, 2021.

F4: This option becomes exercisable as follows: 718 on May 31, 2019; 718 on May 31, 2020; 718 on June 1, 2021; and 718 on May 31, 2022.

F5: This option becomes exercisable as follows: 534 on May 31, 2020; 534 on June 1, 2021; 534 on May 31, 2022; and 534 on May 31, 2023.

F6: This option becomes exercisable as follows: 746 on June 1, 2021; 746 on June 1, 2022; 746 on June 1, 2023; and 746 on June 3, 2024.